Livzon Pharmaceutical Group Inc.

¥31.35As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000513Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 5.42%
Div yield 4.56%
ROE 12.42%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.16
PE TTM 17.88
TSR TTM (7.45%)
Mkt cap ¥24.71B
ROIC 17.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥34
9.77%
(47.19%)
Hold 9|12|5|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.60
0.67
0.67
0.67
15.17%
22.10%
14.09%
8.75%
Revenue¥B
1.621
1.635
1.687
1.642
19.25%
14.82%
11.96%
4.85%
Peers (US$3.705B)
Cap (US$)
PE
3.934B
28.04x
3.738B
6.110x
Capital
TTM
5Y
10Y
Leveragex
1.149
(0.476)
(0.336)
EBIT/Intx
0.547
0.248
0.248
Own earn%
64.19
(120.68)
(127.34)
Sh yield%
31.89
47.47
49.36
Owners
Insiders/Inst%
0.81
44.11
Short interest%
1.96
SBC / revenue%
4.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
16–23
$1 testx
—
Incr. ROIC%
9